We are live on ! Find out more
JIC

Joel Isaacson & Co Portfolio holdings

AUM $3.02B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+21.81%
3 Year Est. Return
+61.27%
5 Year Est. Return
+65.83%
10 Year Est. Return
+229.48%
AUM
$298M
AUM Growth
+$22.6M
Cap. Flow
+$19M
Cap. Flow %
6.38%
Top 10 Hldgs %
62.44%
Holding
613
New
99
Increased
85
Reduced
54
Closed
20

Top Buys

Rank Stock Value
1
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$5.6M
2
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$1.24M
3
VO icon
Vanguard Mid-Cap ETF
VO
+$1.06M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$865K
5
ETO
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
+$734K

Top Sells

Rank Stock Value
1
VSI
Vitamin Shoppe Inc.
VSI
+$676K
2
DWX icon
State Street SPDR S&P International Dividend ETF
DWX
+$524K
3
GAM
General American Investors Company
GAM
+$251K
4
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$214K
5
BEAM
BEAM INC COM STK (DE)
BEAM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 6.58%
2 Technology 4.63%
3 Financials 4.42%
4 Communication Services 4.12%
5 Consumer Staples 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
226
MetLife
MET
$61.2B
$78K 0.03%
1,653
– –
NVS icon
227
Novartis
NVS
$297B
$77K 0.03%
1,004
– –
OMC icon
228
Omnicom Group
OMC
$23.5B
$77K 0.03%
1,060
– –
TWO
229
Two Harbors Investment
TWO
$1.27B
$77K 0.03%
938
– –
GD icon
230
General Dynamics
GD
$105B
$75K 0.03%
693
-447
-39% -$46.3K
TXN icon
231
Texas Instruments
TXN
$255B
$75K 0.03%
1,600
– –
ILMN icon
232
Illumina
ILMN
$28.7B
$74K 0.02%
+514
New +$75.5K
ALXN
233
DELISTED
Alexion Pharmaceuticals
ALXN
$73K 0.02%
480
– –
ABT icon
234
Abbott
ABT
$182B
$72K 0.02%
1,871
+188
+11% +$7.25K
ROBO icon
235
ROBO Global Robotics & Automation Index ETF
ROBO
$1.94B
$72K 0.02%
+2,650
New +$71.4K
BAX icon
236
Baxter International
BAX
$12.1B
$70K 0.02%
1,760
– –
HPQ icon
237
HP
HPQ
$24.3B
$70K 0.02%
4,781
-207
-4% -$2.78K
NYT icon
238
New York Times
NYT
$11.7B
$70K 0.02%
4,101
– –
IWR icon
239
iShares Russell Mid-Cap ETF
IWR
$56.1B
$69K 0.02%
1,792
– –
CLX icon
240
Clorox
CLX
$11.8B
$67K 0.02%
756
+56
+8% +$4.92K
STT icon
241
State Street
STT
$50.7B
$67K 0.02%
960
– –
SQBG
242
DELISTED
Sequential Brands Group, Inc.
SQBG
$67K 0.02%
208
– –
CVG
243
DELISTED
Convergys
CVG
$66K 0.02%
3,000
– –
DOV icon
244
Dover
DOV
$27.7B
$65K 0.02%
990
-203
-17% -$12.6K
GLW icon
245
Corning
GLW
$123B
$65K 0.02%
3,140
– –
MUB icon
246
iShares National Muni Bond ETF
MUB
$45.2B
$64K 0.02%
600
– –
XLE icon
247
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
$64K 0.02%
1,436
– –
MDT icon
248
Medtronic
MDT
$108B
$63K 0.02%
1,025
– –
UPS icon
249
United Parcel Service
UPS
$96B
$63K 0.02%
650
– –
APA icon
250
APA Corp
APA
$12.3B
$62K 0.02%
750
– –
8 9
10
11 12

Similar funds

CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Joel Isaacson & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Joel Isaacson & Co held 613 positions worth $298M, up 8.2% from $275M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Joel Isaacson & Co deployed $19M of net new capital in Q1 2014, opening 99 new positions and adding to 85 existing holdings. Its largest new stake was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 6.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P International Dividend ETF, an estimated $524K trimmed.

  • Joel Isaacson & Co's largest Q1 2014 buy was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.
  • Joel Isaacson & Co added most to State Street SPDR S&P Dividend ETF in Q1 2014, an estimated $5.6M increase.
  • Joel Isaacson & Co's biggest Q1 2014 reduction was State Street SPDR S&P International Dividend ETF, cutting an estimated $524K.
  • Joel Isaacson & Co fully exited Vitamin Shoppe Inc. in Q1 2014, selling an estimated $676K.
  • Joel Isaacson & Co's ten largest holdings make up 62% of its $298M portfolio in Q1 2014.
  • Joel Isaacson & Co opened 99 new positions and closed 20 in Q1 2014.
  • Joel Isaacson & Co's portfolio value rose 8.2% quarter-over-quarter to $298M.

Based on Joel Isaacson & Co's 13F filing for Q1 2014, filed 11 Apr 2014.